Gelibter S, Pirro F, Saraceno L, Susani E, et al. Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience. J Neuroimmunol 2023;383:578199.
PMID: 37717427